Flow Cytometry Kit
A Flow Cytometry Kit provides a comprehensive set of reagents and protocols designed for the analysis of cells or particles in suspension through flow cytometry. The kit facilitates multi-parameter analysis by combining fluorescently labeled antibodies or dyes with optimized buffers and protocols. The following outlines the technical overview, contents, mechanism, and applications of a typical Flow Cytometry Kit.
Content
Assay Components:
- Fluorochrome-Conjugated Antibodies/Probes:
- Antibody Reagents: Monoclonal or polyclonal antibodies tagged with distinct fluorophores (e.g., FITC, PE, APC, PerCP) that specifically bind to cellular antigens.
- Buffers and Solutions:
- Staining Buffer: A buffered solution, often containing proteins (e.g., BSA) or EDTA, to reduce non-specific binding and maintain cell viability during staining.
- Calibration and Standardization Materials:
- Calibration Beads: Fluorescent beads with known fluorescence intensity used for instrument calibration, compensation setup, and performance verification.
Applications
Immunophenotyping:
- Characterizing cell populations in blood, tissues, or cultures based on expression of surface and intracellular markers.
Cell Cycle and Apoptosis Studies:
- Assessing apoptosis via annexin V binding assays or detection of apoptotic markers with fluorescent probes.
Functional Assays:
- Measuring calcium flux, reactive oxygen species production, or phagocytosis using fluorescent indicators.
A Flow Cytometry Kit streamlines the complex process of multi-parameter cellular analysis by providing carefully selected reagents, controls, and protocols optimized for use with flow cytometry instruments. By employing fluorochrome-conjugated antibodies, viability dyes, and standardization materials, researchers and clinicians can reliably identify, quantify, and characterize diverse cell populations and their functional states.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|